Residency · Rochester, MN
Sponsored by Mayo Clinic College of Medicine and Science
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 914 citations · Myra Wick
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 289 citations · Myra Wick
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026.
Journal of the National Comprehensive Cancer Network : JNCCN · 2026 · 33 citations · Myra Wick
Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome.
JAMA oncology · 2021 · 255 citations · Myra Wick
Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database.
EClinicalMedicine · 2023 · 96 citations · Noralane Lindor
Temporal order of clinical and biomarker changes in familial frontotemporal dementia.
Nature medicine · 2022 · 125 citations ·
ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppression.
Developmental cell · 2022 · 138 citations · Haidong Dong
Pregnancy and birth outcomes after SARS-CoV-2 vaccination in pregnancy.
American journal of obstetrics & gynecology MFM · 2021 · 155 citations · Myra Wick